Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

被引:0
|
作者
Vishwanath, Soumya [1 ]
Tran, Stephanie N. [1 ]
Pomfret, Thomas C. [1 ]
Boss, Kaelyn C. [1 ]
Tesell, Mark [1 ]
Price, Mylissa [1 ]
Alper, Caroline J. [1 ]
Muchnik, Lorean [1 ]
Clements, Karen M. [1 ]
Lenz, Kimberly [2 ]
机构
[1] UMass Chan Med Sch Commonwealth Med, 333 South St, Shrewsbury, MA 01545 USA
[2] MassHealth, Off Clin Affairs, Quincy, MA USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2021年 / 27卷 / 11期
关键词
D O I
10.37765/ajmc.2021.88783
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES: To assess the effectiveness of a proactive provider intervention in prompting prior authorization (PA) submissions or provider response prior to PA expiration for medically complex Medicaid patients. STUDY DESIGN: Pre-post outreach study with data from pharmacy claims and provider outreach. METHODS: The intervention and historical comparison (control) groups included expired PAs from December 2019 to February 2020 and from December 2018 to February 2019, respectively. Provider outreach, including telephonic and fax attempts, was conducted over a 2-week period prior to PA expiration. Outcomes were classified as positive or negative based on provider conversation coupled with the result (eg, PA submission) for the intervention group and based solely on pharmacy claims for the control group. The primary end point was the percentage of positive outcomes between the groups, analyzed via chi(2) test. The time from PA expiration to the new PA submission was evaluated via t test. RESULTS: A total of 342 outreach attempts were conducted for 270 PAs representing 193 unique patients. Outreach was more likely to result in positive outcomes in the intervention group vs no outreach in the control group (87% vs 25%; P < .00001). On average, PAs were submitted 3.5 days prior to expiration in the intervention group vs 13.0 days after expiration in the control group (t = -7.50; P < .00001). CONCLUSIONS: Proactive outreach resulted in a greater percentage of PA submissions and a significantly reduced time to PA submission. These findings provide important information for payers in guiding clinical programs to enhance continuity of care among at-risk populations.
引用
收藏
页码:E395 / E399
页数:5
相关论文
共 50 条
  • [41] Prior Authorization for Biologic Disease-Modifying Antirheumatic Drugs: A Description of US Medicaid Programs
    Fischer, Michael A.
    Polinski, Jennifer M.
    Servi, Amber D.
    Agnew-Blais, Jessica
    Kaci, Liljana
    Solomon, Daniel H.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (11): : 1611 - 1617
  • [42] COST-SHARING AND PRIOR AUTHORIZATION EFFECTS ON MEDICAID SERVICES IN CALIFORNIA .2. REPLY
    KUEHL, AE
    MEDICAL CARE, 1976, 14 (06) : 545 - 546
  • [43] EFFECT OF ATYPICAL ANTIPSYCHOTIC PRIOR AUTHORIZATION IMPLEMENTATION ON PATIENT OUTCOMES AMONG OHIO MEDICAID BENEFICIARIES
    Thompson, J. A.
    Kelton, C. M.
    Lin, A. C.
    Winstanley, E. L.
    Heaton, P. C.
    VALUE IN HEALTH, 2017, 20 (05) : A303 - A304
  • [44] Perceived Timeliness of Prior Authorization Approvals for Medicaid Home- and Community-Based Services
    Mellor, Jennifer M.
    Cunningham, Peter J.
    Britton, Erin
    Mitchell, Andrew
    Dagenhart, Sandra
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2025,
  • [45] Early effects of an FDA advisory regarding antipsychotics medications on US medicaid prior authorization programs
    Polinski, Jennifer
    Fischer, Michael
    Servi, Amber
    Robinson, Elizabeth
    Wang, Philip
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S35 - S35
  • [46] Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications
    Farley, Joel F.
    Cline, Richard R.
    Schommer, Jon C.
    Hadsall, Ronald S.
    Nyman, John A.
    CLINICAL THERAPEUTICS, 2008, 30 (08) : 1524 - 1539
  • [47] Burden of Prior Authorization Requirements on Urology Practice and Patients
    Sundaram, Padmaja
    Bhatt, Vikas
    Feustel, Paul
    Mian, Badar
    UROLOGY, 2022, 169 : 76 - +
  • [48] Burden of Prior Authorization Requirements on Urology Practice and Patients
    Sundaram, Padmaja
    Bhatt, Vikas
    Feustel, Paul
    Mian, Badar
    UROLOGY, 2022, 169 : 76 - 82
  • [49] Impact of NSAIDs prior authorization policy on patients' QoL
    Momani, AA
    Madhavan, SS
    Nau, DP
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1686 - 1691
  • [50] Prior Authorization Policies and Preferred Drug Lists in Medicaid Plans: Stakeholder Perspectives on the Implications for Youth with ADHD
    Sarah C. Blake
    Minna Song
    Laura Gaydos
    Janet R. Cummings
    Administration and Policy in Mental Health and Mental Health Services Research, 2019, 46 : 580 - 595